You are here: Home Sector Focus Life Science
Life Science
Più recente
281 a 290 di 344
-
Articolo
Ultima consultazione: 08 September 2008 / Inviato: 09 May 2008
The Court of Appeal ruled that certain information relating to the use of animals in scientific procedures was not disclosable by the Home Office.
-
Articolo
Ultima consultazione: 17 April 2008 / Inviato: 17 April 2008
The commission`s inquiry could have far reaching consequences.
-
Articolo
Ultima consultazione: 10 April 2008 / Inviato: 10 April 2008
Indirect purchasers have issued a further follow on claim arising out of the vitamins cartel.
-
Articolo
Ultima consultazione: 01 April 2008 / Inviato: 01 April 2008
Advocate General Colomer has issued his advisory opinion in Sot. Lelos and others v GSK (the `Syfait 2` case). In his view, a dominant pharmaceutical company that refuses to meet orders from wholesalers in order to limit parallel trade is abusing its dom
-
Articolo
Ultima consultazione: 20 March 2008 / Inviato: 20 March 2008
The Economic Committee of Health Products now has the power to fine pharmaceutical companies and it appears determined to exercise its prerogatives.
-
Articolo
Ultima consultazione: 20 March 2008 / Inviato: 20 March 2008
In UK Budget 2008, the Chancellor confirmed that increases to the rates of R&D tax relief for all companies first announced in Budget 2007 will go ahead.
-
Articolo
Ultima consultazione: 20 March 2008 / Inviato: 20 March 2008
The voluntary addition of vitamins, minerals and other substances to food in Europe is regulated by Regulation (EC) No 1925/2006 of 20 December 2006 as amended by Regulation (EC) 108/2008 of 15 January 2008.
-
Articolo
Ultima consultazione: 19 February 2008 / Inviato: 19 February 2008
Legislative Decree 191 (November 2007) sets out quality and safety standards for donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells.
-
Articolo
Ultima consultazione: 19 February 2008 / Inviato: 19 February 2008
Around one in six new class actions filings are against biotechnology and pharmaceutical companies.
-
Articolo
Ultima consultazione: 19 February 2008 / Inviato: 19 February 2008
The first Chamber for Commercial Matters of the Regional Court in Munich has found that pharmaceutical companies are not allowed to give doctors `expensive gifts`.
281 a 290 di 344